Block, Report, And Suspend Suspicious Shipments Act of 2020
This bill creates additional requirements for drug manufacturers and distributors who discover a suspicious order for controlled substances.
In addition to reporting the suspicious order to the Drug Enforcement Administration (DEA), a manufacturer or distributor must also exercise due diligence and decline to fill the order.
The DEA must issue regulations specifying the indicators that give rise to a suspicious order.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.